TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 6 | 2 | -22 | -47 | -54 | 44 | -12 |
| P | %wins | 100 | 100 | 0 | 0 | 0 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/13/14 16:06 | 8/13/14 | OGEN | Oragenics Inc | FL | Health | Drug | Pharmaceutical Preparations | Bonfiglio John N | FL | DO | P,CEO | P | 2 | 1.70 | 0 | 1 | 0 | 385 | D | -36 | -43 | -49 | -9 | -10 | -11 | 0 | 0 | 6 | 2 | -22 | -47 | -54 | 44 |
8/16/11 15:33 | 8/16/11 | ORNI | Oragenics Inc | FL | Health | Drug | Pharmaceutical Preparations | Bonfiglio John N | FL | DO | P,CEO | P | 3 | 2.15 | 0 | 1 | New | 1 | D | ||||||||||||||
9/6/05 13:59 | 9/2/05 | IMNR | Immune Response Corp | DE | Health | BioPrd | Biological Products, (No Diag | Bonfiglio John N | CA | DO | CEO | P | 5 | 0.4600 | 0 | 10 | 31 | 42 | D | ||||||||||||||
8/12/04 14:00 | 8/10/04 | IMNR | Immune Response Corp | DE | Health | BioPrd | Biological Products, (No Diag | Bonfiglio John N | CA | DO | CEO | P.a | 3 | 0.6600 | 0 | 5 | 51 | 15 | D | ||||||||||||||
5/19/04 17:44 | 5/18/04 | IMNR | Immune Response Corp | DE | Health | BioPrd | Biological Products, (No Diag | Bonfiglio John N | CA | DO | CEO | P | 7 | 1.41 | 0 | 5 | New | 5 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |